Analyst Insights: Fluidigm, Pacific Biosciences, CSX, Apache, American Express March 27th

American Express Company (NYSE:AXP): CLSA raised American Express estimates citing its near-term plans to return capital to shareholders. Shares are Buy rated.

Fluidigm Corporation (ADR) (NASDAQ:FLDM): Deutsche Bank removed Fluidigm from its short-term buy list due to an analyst departure.

Pacific Biosciences of California, Inc. (NASDAQ:PACB): Deutsche Bank removed Pacific Biosciences from its short-term buy list due to an analyst departure.

CSX Corp. (NYSE:CSX): CSX added to short-term buy list at Deutsche Bank

Apache Corp. (NYSE:APA): Credit Suisse views Apache as the cheapest large cap E&P with 8%-10% production growth in 2012. The firm reiterates its Outperform rating and recommends purchase.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.